2 results match your criteria: "and Blood Institute. Electronic address: clare.sun@nih.gov.[Affiliation]"
Vaccinations in patients with chronic lymphocytic leukemia.
Semin Hematol
April 2024
National Institutes of Health, National Heart, Lung, and Blood Institute. Electronic address:
Chronic lymphocytic leukemia (CLL) is characterized by immune dysfunction resulting in heightened susceptibility to infections and elevated rates of morbidity and mortality. A key strategy to mitigate infection-related complications has been immunization against common pathogens. However, the immunocompromised status of CLL patients poses challenges in eliciting an adequate humoral and cellular immune response to vaccination.
View Article and Find Full Text PDFCOVID-19 vaccines for patients with haematological conditions.
Lancet Haematol
May 2021
Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.